Scleroderma Renal Crisis Complicated by Hemolytic Uremic Syndrome in a Case of Elderly Onset Systemic Sclerosis

Journal of Dermatology

Volumn 24, Issue 3, 1997, Pages 184-188

  Yamanaka, Kei Ichi ^a   Mizutani, Hitoshi ^a   Hashimoto, Kenji ^a   Nishii, Masami ^b   Shimizu, Masayuki ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ise Municipal Hospital   (Japan)

Author keywords

Captopril; Hemodialysis; Malignant hypertension; Prostaglandin E1; Scleroderma kidney

Indexed keywords

ACUTE DISEASE; ARTICLE; CASE REPORT; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; MIDDLE AGED; PATHOLOGY; SKIN; SYSTEMIC SCLEROSIS;

ACUTE DISEASE; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY FAILURE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0031088078     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02769.x     Document Type: Article

References (10)

1. Traub YM, Shapiro AP, Rodnan GP, et al: Hypertension and renal failure (Scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases, Medicine, 62: 335-352, 1983.
2. Zawada ETJr, Clelents PJ, Furst DA, Bloomer HA, Paulus HE, Maxwell MH: Clinical course of patients with scleroderma renal crisis treated with captopril, Nephron, 27: 74-78, 1981.
3. Whitman HH, Case DB, Laragh JH, et al: Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients, Arth Rheum, 25: 241-245, 1982.
4. Sorensen LB, Panunicka K, Harris M: Reversal of scleroderma renal crisis for more than two years in a patient treated with captopril, Arth Rheum, 26: 797-800, 1983.
5. Steen VD, Medsger TA Jr, Osial TA Jr, Ziegler GL, Shapiro AP, Rodnan GP: Factors predicting development of renal involvement in progressive systemic sclerosis, Am J Med, 76: 779-786, 1984.
6. Kashiwazaki S: Scleroderma renal crisis, Rheumatism, 26: 126-133, 1986. (in Japanese)
7. Rodnan GP, Schreiner GE, Black RL: Renal involvement in progressive systemic sclerosis (generalized scleroderma), Am J Med, 23: 445-462, 1957.
8. McWhorten JE, Le Roy EC: Pericardial disease in scleroderma (systemic sclerosis), Am J Med, 57: 566-575, 1974.
9. Gay S, Jones R Jr, Huang GQ, Gay RE: Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sisoncogene expression in scleroderma, J Invest Dermatol, 92: 301-303, 1989.
10. Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC: The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and cortical circulation, Medicine, 53: 1-46, 1974.